SCHEMBL9251867

SCHEMBL9251867

Cc1ccc2nc(-c3ccccc3Br)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
MAOB P27338 2/20 0.48
MAOA P21397 1/20 0.48
BACE1 P56817 2/20 0.46
NCK1 P16333 1/20 0.46
PSMB5 P28074 1/20 0.44
ALDH1A1 P00352 2/20 0.42
NQO2 P16083 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
CYP2A6 P11509 1/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ESR1 P03372 1/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298989 0.83 CYP1A2 (0.52) CYP1A2BACE1NCK1PSMB5ALDH1A1
SCHEMBL9255457 0.81 CYP1A2 (0.49) CYP1A2MAOBMAOABACE1NCK1
SCHEMBL14269740 0.81 MBNL1 (0.50) CYP1A2BACE1NCK1PSMB5ALDH1A1
SCHEMBL18944032 0.79 ALDH1A1 (0.48) CYP1A2MAOBMAOABACE1NCK1
SCHEMBL28063766 0.79 RAB9A (0.50) CYP1A2ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL30462939 0.79 RAB9A (0.50) CYP1A2ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL23247265 0.78 CYP1A2 (0.68) CYP1A2BACE1NCK1PSMB5ALDH1A1
SCHEMBL13298987 0.77 CYP1A2 (0.49) CYP1A2BACE1NCK1PSMB5ALDH1A1
SCHEMBL8482877 0.77 KDM4E (0.47) CYP1A2BACE1NCK1PSMB5ALDH1A1
SCHEMBL13298969 0.76 CYP1A2 (0.55) CYP1A2MAOBMAOABACE1NCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5457112-A Glaucoma, hypotensive agents SYNTHELABO (FR) 1995-10-10 US disclosed
EP-0540400-B1 Quinoline derivatives, useful as angiotensin II antagonists SYNTHELABO (FR) 1995-08-23 EP disclosed
US-5432283-A Substituted phenyl in 2 position; intermediates for drugs to treat hypertensive pathologies, cardiac, renal or pulmonary insufficiencies, and glaucoma SYNTHELABO (FR) 1995-07-11 US disclosed
US-5371227-A Quinoline derivatives, process for their preparation, and their therapeutic applications SYNTHELABO (FR) 1994-12-06 US disclosed
EP-0604259-A1 3-(Quinolin-6-yl-methyl)-4H-imidazol-4-one derivatives as angiotensin II antagonists SYNTHELABO (FR) 1994-06-29 EP disclosed
EP-0540400-A1 Quinoline derivatives, useful as angiotensin II antagonists SYNTHELABO (FR) 1993-05-05 EP disclosed